Hidradenitis Suppurativa Market

Hidradenitis Suppurativa Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

250

Base Year:

2024

Dec - 2024

Format:

Report Code:

VMR-3921

Segments Covered

By Clinical Stages Hurley Stage 1-Low, Hurley Stage 2-Moderate, Hurley Stage 3-High
By Treatment Type Medication, Surgery
By Route of Administration Oral, Tropical
By End Users Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4099 USD

Multi User License

$ 5250 USD

Enterprise License

$ 6400 USD

Snapshot

Base Year:	2024
Forecast Years:	2025 - 2035
Historical Years:	2019 - 2023
Revenue 2024:	USD 894.3 Million
Revenue 2035:	USD 1315.3 Million
Revenue CAGR (2025 - 2035):	4.9%
Fastest Growing Region (2025 - 2035)	Europe
Largest Region (2024):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Hidradenitis Suppurativa Market - Segment Analysis
1. Overview
2. Global Hidradenitis Suppurativa Market, 2016 - 2028 (USD Million)
3. Global Hidradenitis Suppurativa Market - by Clinical Stages
  1. By Hurley Stage 1-Low
  2. By Hurley Stage 2-Moderate
  3. By Hurley Stage 3-High
4. Global Hidradenitis Suppurativa Market - by Treatment Type
  1. By Medication
  2. By Surgery
5. Global Hidradenitis Suppurativa Market - by Route of Administration
  1. By Oral
  2. By Tropical
6. Global Hidradenitis Suppurativa Market - by End Users
  1. By Hospital Pharmacy
  2. By Retail Pharmacy
  3. By Online Pharmacy
7. Global Hidradenitis Suppurativa Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
8. Market comparative analysis
North America Hidradenitis Suppurativa Market - Segment Analysis
1. Overview
2. North America Hidradenitis Suppurativa Market, 2016 - 2028 (USD Million)
3. North America Hidradenitis Suppurativa Market, by Clinical Stages
  1. By Hurley Stage 1-Low
  2. By Hurley Stage 2-Moderate
  3. By Hurley Stage 3-High
4. North America Hidradenitis Suppurativa Market, by Treatment Type
  1. By Medication
  2. By Surgery
5. North America Hidradenitis Suppurativa Market, by Route of Administration
  1. By Oral
  2. By Tropical
6. North America Hidradenitis Suppurativa Market, by End Users
  1. By Hospital Pharmacy
  2. By Retail Pharmacy
  3. By Online Pharmacy
7. North America Hidradenitis Suppurativa Market, by Country
  1. U.S.
    1. U.S. Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. U.S. Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. U.S. Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. U.S. Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
  2. Canada
    1. Canada Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. Canada Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. Canada Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. Canada Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
  3. Mexico
    1. Mexico Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. Mexico Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. Mexico Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. Mexico Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
Europe Hidradenitis Suppurativa Market - Segment Analysis
1. Overview
2. Europe Hidradenitis Suppurativa Market, 2016 - 2028 (USD Million)
3. Europe Hidradenitis Suppurativa Market, by Clinical Stages
  1. By Hurley Stage 1-Low
  2. By Hurley Stage 2-Moderate
  3. By Hurley Stage 3-High
4. Europe Hidradenitis Suppurativa Market, by Treatment Type
  1. By Medication
  2. By Surgery
5. Europe Hidradenitis Suppurativa Market, by Route of Administration
  1. By Oral
  2. By Tropical
6. Europe Hidradenitis Suppurativa Market, by End Users
  1. By Hospital Pharmacy
  2. By Retail Pharmacy
  3. By Online Pharmacy
7. Europe Hidradenitis Suppurativa Market, by Country
  1. Germany
    1. Germany Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. Germany Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. Germany Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. Germany Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
  2. UK
    1. UK Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. UK Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. UK Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. UK Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
  3. France
    1. France Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. France Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. France Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. France Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
  4. Spain
    1. Spain Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. Spain Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. Spain Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. Spain Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
  5. Italy
    1. Italy Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. Italy Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. Italy Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. Italy Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
  6. BENELUX
    1. BENELUX Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. BENELUX Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. BENELUX Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. BENELUX Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
  7. Rest of Europe
    1. Rest Of Europe Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. Rest Of Europe Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. Rest Of Europe Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. Rest Of Europe Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
Asia Pacific Hidradenitis Suppurativa Market - Segment Analysis
1. Overview
2. Asia Pacific Hidradenitis Suppurativa Market, 2016 - 2028 (USD Million)
3. Asia Pacific Hidradenitis Suppurativa Market, by Clinical Stages
  1. By Hurley Stage 1-Low
  2. By Hurley Stage 2-Moderate
  3. By Hurley Stage 3-High
4. Asia Pacific Hidradenitis Suppurativa Market, by Treatment Type
  1. By Medication
  2. By Surgery
5. Asia Pacific Hidradenitis Suppurativa Market, by Route of Administration
  1. By Oral
  2. By Tropical
6. Asia Pacific Hidradenitis Suppurativa Market, by End Users
  1. By Hospital Pharmacy
  2. By Retail Pharmacy
  3. By Online Pharmacy
7. Asia Pacific Hidradenitis Suppurativa Market, by Country
  1. China
    1. China Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. China Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. China Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. China Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
  2. Japan
    1. Japan Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. Japan Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. Japan Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. Japan Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
  3. India
    1. India Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. India Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. India Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. India Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
  4. South Korea
    1. South Korea Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. South Korea Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. South Korea Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. South Korea Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
  5. South East Asia
    1. South East Asia Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. South East Asia Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. South East Asia Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. South East Asia Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. Rest of Asia Pacific Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. Rest of Asia Pacific Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. Rest of Asia Pacific Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
Latin America Hidradenitis Suppurativa Market - Segment Analysis
1. Overview
2. Latin America Hidradenitis Suppurativa Market, 2016 - 2028 (USD Million)
3. Latin America Hidradenitis Suppurativa Market, by Clinical Stages
  1. By Hurley Stage 1-Low
  2. By Hurley Stage 2-Moderate
  3. By Hurley Stage 3-High
4. Latin America Hidradenitis Suppurativa Market, by Treatment Type
  1. By Medication
  2. By Surgery
5. Latin America Hidradenitis Suppurativa Market, by Route of Administration
  1. By Oral
  2. By Tropical
6. Latin America Hidradenitis Suppurativa Market, by End Users
  1. By Hospital Pharmacy
  2. By Retail Pharmacy
  3. By Online Pharmacy
7. Latin America Hidradenitis Suppurativa Market, by Country
  1. Brazil
    1. Brazil Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. Brazil Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. Brazil Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. Brazil Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
  2. Argentina
    1. Argentina Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. Argentina Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. Argentina Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. Argentina Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
  3. Rest of Latin America
    1. Rest of Latin America Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. Rest of Latin America Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. Rest of Latin America Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. Rest of Latin America Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
Middle East & Africa Hidradenitis Suppurativa Market - Segment Analysis
1. Overview
2. Middle East & Africa Hidradenitis Suppurativa Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Hidradenitis Suppurativa Market, by Clinical Stages
  1. By Hurley Stage 1-Low
  2. By Hurley Stage 2-Moderate
  3. By Hurley Stage 3-High
4. Middle East & Africa Hidradenitis Suppurativa Market, by Treatment Type
  1. By Medication
  2. By Surgery
5. Middle East & Africa Hidradenitis Suppurativa Market, by Route of Administration
  1. By Oral
  2. By Tropical
6. Middle East & Africa Hidradenitis Suppurativa Market, by End Users
  1. By Hospital Pharmacy
  2. By Retail Pharmacy
  3. By Online Pharmacy
7. Middle East & Africa Hidradenitis Suppurativa Market, by Country
  1. GCC Countries
    1. GCC Countries Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. GCC Countries Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. GCC Countries Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. GCC Countries Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
  2. South Africa
    1. South Africa Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. South Africa Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. South Africa Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. South Africa Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Hidradenitis Suppurativa Market, By Clinical Stages
      1. By Hurley Stage 1-Low
      2. By Hurley Stage 2-Moderate
      3. By Hurley Stage 3-High
    2. Rest of Middle East & Africa Hidradenitis Suppurativa Market, By Treatment Type
      1. By Medication
      2. By Surgery
    3. Rest of Middle East & Africa Hidradenitis Suppurativa Market, By Route of Administration
      1. By Oral
      2. By Tropical
    4. Rest of Middle East & Africa Hidradenitis Suppurativa Market, By End Users
      1. By Hospital Pharmacy
      2. By Retail Pharmacy
      3. By Online Pharmacy
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. InfraRx N.V.
2. Novartis AG
3. UCB Biopharma SPRL
4. AbbVie Inc
5. Eli Lily and Company
6. Aristea Therapeutics Inc.te Corporation
7. Janssen Pharmaceuticals
8. Priovant Therapeutics
9. Amgen Inc
10. Aclaris Therapeutics Inc
11. Boehringer Ingelheim
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

Vantage Market Research | 16-Jan-2025

Hidradenitis Suppurativa (HS) Market to Reach USD 1315.3 Million by 2035

FAQ

Frequently Asked Question

What is the global demand for Hidradenitis Suppurativa in terms of revenue?

The global Hidradenitis Suppurativa valued at USD 894.3 Million in 2024 and is expected to reach USD 1315.3 Million in 2035 growing at a CAGR of 4.9%.

Which are the prominent players in the market?

The prominent players in the market are InfraRx N.V., Novartis AG, UCB Biopharma SPRL, AbbVie Inc, Eli Lily and Company, Aristea Therapeutics, Incyte Corporation, Janssen Pharmaceuticals, Priovant Therapeutics, Amgen Inc, Aclaris Therapeutics Inc, Boehringer Ingelheim.

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 4.9% between 2025 and 2035.

What are the driving factors fueling the growth of the market.

The driving factors of the Hidradenitis Suppurativa include

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Hidradenitis Suppurativa in 2024.

Hidradenitis Suppurativa Market

Hidradenitis Suppurativa Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Hidradenitis Suppurativa in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Hidradenitis Suppurativa Market

Hidradenitis Suppurativa Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Hidradenitis Suppurativa in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Hidradenitis Suppurativa Market

Vantage Point Interactive Dashboard